CardioSignal
Kristiina Santalahti has a diverse work experience in the field of research and quality management. Kristiina is currently working as the Research and Quality Director at CardioSignal by Precordior, a company that develops mobile application-based technology for the detection of heart diseases. Prior to this role, they served as the Research Director at the same company. Kristiina also worked as the Clinical Product Quality Manager at CardioSignal.
Before joining CardioSignal, Kristiina worked at Precordior Ltd as a Product Quality Manager. Kristiina was responsible for ensuring the quality of their products.
Kristiina's academic background includes working at the University of Turku. Kristiina was a Postdoctoral Researcher from 2018 to 2019 and a PhD Student from 2008 to 2018. Kristiina also worked as a Research Assistant from 2005 to 2007.
Throughout their career, Kristiina has gained extensive experience in research, quality management, and product development in the medical field.
Kristiina Santalahti attended the University of Turku from 2003 to 2008, where they earned a Master of Science (M.Sc.) degree in Biochemistry. Kristiina then continued their education at the same university, from 2008 to 2018, and obtained a Doctor of Philosophy (PhD) degree in Biomedicine.
CardioSignal
CardioSignal offers a digital cardiac biomarker for self-monitoring, remote care, and point-of-care diagnostics. CardioSignal's patented technology enables a digital cardiac biomarker for several major heart diseases, representing a breakthrough in the fight against heart disease, the world's most expensive and lethal disease.CardioSignal's digital cardiac biomarkers can replace invasive and expensive standard care technologies, allowing for faster and less expensive care.